Tenofovir disoproxil fumarate exhibits strong antiviral effect in a patient with lamivudine-resistant severe hepatitis B reactivation

被引：28
|
作者：
Van Bömmel, F [1 ]
Schernick, A [1 ]
Hopf, U [1 ]
Berg, T [1 ]
机构：
[1] Humboldt Univ, Charite, Med Klin Scherpunkt Hepatol & Gastroenterol, Berlin, Germany
来源：
GASTROENTEROLOGY | 2003年 / 124卷 / 02期
关键词：
D O I：
10.1053/gast.2003.1240586b
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：586 / 587
页数：2
相关论文
共 50 条
  • [1] Tenofovir Disoproxil Fumarate for the Treatment of Lamivudine-Resistant Hepatitis B
    Kuo, Alexander
    Dienstag, Jules L.
    Chung, Raymond T.
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2004, 2 (03) : 266 - 272
  • [2] Randomized Comparison of Tenofovir Disoproxil Fumarate vs Emtricitabine and Tenofovir Disoproxil Fumarate in Patients With Lamivudine-Resistant Chronic Hepatitis B
    Fung, Scott
    Kwan, Peter
    Fabri, Milotka
    Horban, Andrzej
    Pelemis, Mijomir
    Hann, Hie-Won
    Gurel, Selim
    Caruntu, Florin A.
    Flaherty, John F.
    Massetto, Benedetta
    Dinh, Phillip
    Corsa, Amoreena
    Subramanian, G. Mani
    McHutchison, John G.
    Husa, Petr
    Gane, Edward
    GASTROENTEROLOGY, 2014, 146 (04) : 980 - U521
  • [3] Tenofovir disoproxil fumarate in patients with HIV and lamivudine-resistant hepatitis B virus.
    Benhamou, Y
    Tubiana, R
    Thibault, V
    NEW ENGLAND JOURNAL OF MEDICINE, 2003, 348 (02): : 177 - 178
  • [4] Tenofovir disoproxil fumarate is superior to lamivudine plus adefovir in lamivudine-resistant chronic hepatitis B patients
    Yang, Dan-Hong
    Xie, Yuan-Jun
    Zhao, Nian-Feng
    Pan, Hong-Ying
    Li, Ming-Wei
    Huang, Hai-Jun
    WORLD JOURNAL OF GASTROENTEROLOGY, 2015, 21 (09) : 2746 - 2753
  • [5] Tenofovir disoproxil fumarate is superior to lamivudine plus adefovir in lamivudine-resistant chronic hepatitis B patients
    Dan-Hong Yang
    Yuan-Jun Xie
    Nian-Feng Zhao
    Hong-Ying Pan
    Ming-Wei Li
    Hai-Jun Huang
    World Journal of Gastroenterology, 2015, (09) : 2746 - 2753
  • [6] Tenofovir disoproxil fumarate effect in a patient with lamivudine resistant hepatitis B awaiting liver transplantation.
    Araya, VR
    Rothstein, K
    Ortiz, J
    Reich, D
    Manzarbeitia, C
    Munoz, S
    HEPATOLOGY, 2002, 36 (04) : 645A - 645A
  • [7] No Resistance to Tenofovir Disoproxil Fumarate Through 96 Weeks of Treatment in Patients With Lamivudine-Resistant Chronic Hepatitis B
    Corsa, Amoreena C.
    Liu, Yang
    Flaherty, John F.
    Ben Mitchell
    Fung, Scott K.
    Gane, Edward
    Miller, Michael D.
    Kitrinos, Kathryn M.
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2014, 12 (12) : 2106 - U393
  • [8] Evaluating the efficacy of switching from lamivudine plus adefovir to tenofovir disoproxil fumarate monotherapy in lamivudine-resistant stable hepatitis B patients
    Lee, Heon Ju
    Kim, Sang Jin
    Kweon, Young Oh
    Park, Soo Young
    Heo, Jeong
    Woo, Hyun Young
    Hwang, Jae Seok
    Chung, Woo Jin
    Lee, Chang Hyeong
    Kim, Byung Seok
    Suh, Jeong Ill
    Tak, Won Young
    Jang, Byoung Kuk
    PLOS ONE, 2018, 13 (01):
  • [9] A randomized trial evaluating the antiviral efficacy of switching from lamivudine plus adefovir to tenofovir disoproxil fumarate monotherapy in lamivudine-resistant chronic hepatitis B patients with undetectable hepatitis B virus DNA
    Lee, Heon Ju
    Kim, SangJin
    Kweon, Young-Oh
    Park, Soo Young
    Heo, Jeong
    Woo, Hyun Young
    Hwang, Jaeseok
    Chung, Woo Jin
    Lee, Chang-Hyeong
    Kim, Byung Seok
    Suh, Jeong Ill
    Tak, Won Young
    Jang, Byoung Kuk
    HEPATOLOGY, 2016, 64 : 926A - 927A
  • [10] EFFICACY OF TENOFOVIR DISOPROXIL FUMARATE TO PREVENT VERTICAL TRANSMISSION IN MOTHERS WITH LAMIVUDINE-RESISTANT HBV
    Liu, J.
    Wang, J.
    Cao, F.
    Yan, T.
    Qi, C.
    Chen, T.
    Zhao, Y.
    JOURNAL OF HEPATOLOGY, 2015, 62 : S287 - S287
12345